Figure 2From: Transcriptional profiling of the effects of 25-hydroxycholesterol on human hepatocyte metabolism and the antiviral state it conveys against the hepatitis C virusHCV replicons and their use in transcriptional profiling with 25-hydroxycholesterol treatment. (a) HCV genome and HCV subgenomic replicon constructs used in this study. (b) Experimental design for Affymetrix GeneChip experiments using HCV luc/NS3-3'/5.1 replicon RNA.Back to article page